Beranda › Kanker Prostat › Montana › Billings
Uji klinis Kanker Prostat di Billings, MT
15 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Billings (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Billings Clinic Cancer Center, Billings
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Menerima pesertaFase 2
- Billings Clinic Cancer Center, Billings
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
- Billings Clinic Cancer Center, Billings
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Menerima pesertaFase 3
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Menerima pesertaFase 3
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Menerima pesertaFase 2
- Billings Clinic Cancer Center, Billings
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Billings
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Billings
- Kanker Paru Non-Sel Kecil17 studi
- Kanker Paru13 studi
- Kanker Payudara10 studi
- Kanker Ovarium9 studi
- Melanoma7 studi
- Leukemia Limfositik Kronis7 studi
- Kanker Kolorektal6 studi
- Kanker Kolon6 studi
- Kanker Kandung Kemih6 studi
- Leukemia Mieloid Akut6 studi
- Kanker Rektum5 studi
- Kanker Endometrium4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.